Transcription factors serve critical roles in the progressive development of general body plan, organ commitment, and finally, specific cell types. It has been the hope of most developmental biologists that comparison of the biological roles of a series of individual members within a family will permit at least some predictive generalizations regarding the developmental events that are likely to be regulated by a particular class of transcription factors. Here, we present an overview of the developmental functions of the family of transcription factors characterized by the POU DNA-binding motif afforded by recent in vivo studies.
The POU domain family of transcription factors was defined following the observation that the products of three mammalian genes, Pit-l, Oct-l, and Oct-2 and the protein encoded by the Caenorhabditis elegans gene unc-86 shared a region of homology, known as the POU domain (Bodner et al. 1988; Clerc et al. 1988; Herr et al. 1988; Ingraham et al. 1988; Ko et al. 1988; MUller et al. 1988; Scheidereit et al. 1988; . The POU domain is a bipartite DNA-binding domain Ingraham et al. 1990; Botfield et al. 1992; Verrijzer et al. 1992) , consisting of two highly conserved regions tethered by a variable linker. The -75-amino acid amino-terminal region was called the POU-specific domain and the carboxy-terminal 60-amino acid region, the POU homeodomain.
POU domain proteins have been identified from a diverse range of species (Table 1) . Although currently grouped into six or seven classes based on the amino acid sequence of their POU domains and conservation of the variable linker region (Wegner et al. 1993a) , the recent identification and characterization of several new POU domain proteins suggests that some classes may be further subdivided (Spaniol et al. 1996) . The in vivo functions of many POU proteins have been examined through targeted gene disruption in the mouse and characterization of loss-of-function and gain-of-function mutations in Drosophila, C. elegans, and Xenopus. These in vivo studies demonstrate that POU domain proteins regulate key developmental processes and will be the ~Corresponding author. E-MAIL mrosenfeld@ucsd.edu; FAX (619) 534-8180. primary focus of this review. Crystallization of the Oct-1 and Pit-1 POU domains on DNA and in vitro studies examining the specificity of POU domain cofactor interactions suggest that the flexibility with which the POU domain recognizes DNA-binding sites is a critical component of its ability to regulate gene expression. The implications of these data with respect to the mechanisms utilized by the POU domain family of transcription factors to control developmental events will also be discussed.
Conformation of the POU domain on DNA
High-affinity site-specific DNA binding by POU domain transcription factors requires both the POU-specific domain and the POU homeodomain Ingraham et al. 1990 ; Kristie and Sharp 1990; Verrijzer et al. 1990 Verrijzer et al. , 1992 . The two subdomains can cooperatively bind DNA even when they are not joined by the linker (Klemm and Pabo 1996) . Resolution of the crystal structures of Oct-1 and Pit-1 POU domains bound to DNA as a monomer and homodimer, respectively, confirmed several of the in vitro findings regarding interactions of this bipartite DNA-binding domain with DNA and has provided important information regarding the flexibility and versatility of POU domain proteins (Klemm et al. 1994; Jacobson et al. 1997) .
Structure of Oct-1 bound to an octamer DNA-binding site
Overall the crystal structure of a monomer of the Oct-1 POU domain bound to the octamer element was similar to that predicted by the nuclear magnetic resonance (NMR) solution structures of the POU-specific domain (Assa-Munt et al. 1993; Dekker et al. 1993 ) and the POU homeodomain (Sivaraja et al. 1994; Cox et al. 1995; Morita et al. 1995) in isolation. The POU-specific domain consists of four ~ helices, with the second and third helices forming a structure similar to the helix-turnhelix motif of the K and 434 repressors; several of the DNA base contacts are also conserved (Klemm et al. 1994) . Although the primary sequence of the Oct-1 POU homeodomain is considerably divergent from those of classic homeodomains, it is structurally conserved and 
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docks against the DNA in a manner that is analogous to other homeodomain proteins (Klemm et al. 1994) . Both the POU-specific domain and the POU homeodomain make extensive base and phosphate backbone contacts with the DNA, and as predicted by in vitro experiments (for review, see Herr and Cleary 1995) , the POU-specific domain binds the 5' ATGC portion of the octamer element and the POU homeodomain binds the 3' A/T-rich portion of the site (Klemm and Pabo 1994) . The Oct-1 POU-specific domain and the POU homeodomain bind to opposite faces of the DNA helix, yet despite overlapping DNA contacts near the center of the octamer element, they do not interact (Fig. 1A) . The overlapping contacts made by the Oct-1 POU-specific domain and POU homeodomain are presumed to be important for mediating the cooperative binding of these two subdomains. Although binding site selection studies suggested that Oct-1 will recognize either an A or a T at position 5 in the octamer element (Verrijzer et al. 1992) , an A/T base pair at this position, as opposed to a T/A base pair, is critical for the cooperative binding of the POU-specific domain and POU homeodomain, as is the Figure 1 . Schematic representation of the crystal structures of Oct-1 and Pit-1 bound to DNA. (A) Diagrammatic representation of the crystal structure of an Oct-1 POU domain monomer bound to an octamer element (ATGCAAAT on the lower strand). The Oct-1 POU-specific and POU homeodomains bind to opposite faces of the DNA and have a tail-to-tail orientation. The positionings of the Oct-1 POU-specific domain (POUs) and POU homeodomain (POUH) on the ATGC and AAAT half-sites, respectively, are diagramed on the sequence below. (B) Diagrammatic representation of a Pit-1 POU domain homodimer bound to a dimer recognition site. The sequence contacted by the Pit-1 POU domains is an inverted palindrome, ATGTATATACAT. In contrast to the Oct-1 monomer, the Pit-1 POU-specific domain (POUs) and the POU homeodomain (POUH) in each monomer bind the DNA in a head-to-tail orientation and the linker does not cross the minor groove. The orientation of the four POU subdomains in the dimer, when bound to DNA, are indicated on the sequence be-
spacing of the two subsites (Klemm and Pabo 1996) . Adenine is the more common base at this position in naturally occurring octamer sites within cellular promoters, suggesting that additional constraints are involved for the in vivo function of Oct-1 on octamer elements (K1-e m m et al. 1994).
Crystal structure of a Pit-1 h o m o d i m e r on D N A
A homodimer of the Pit-1 POU domain was crystallized bound to a functional Pit-1 dimer D N A element that is closely related to a site in the proximal promoter of the prolactin gene (Jacobson et al. 19971 . The structure of the Pit-1 POU domain on D N A is very similar to that of Oct-1, and the Pit-1 POU h o m e o d o m a i n / D N A structure is strikingly similar to that of other homeodomains, including the Oct-1 POU homeodomain. The D N A contacts made by the Pit-1 POU-specific domain are also similar to those of Oct-1 and conserved with many made by the prokaryotic repressors. In the Oct-1 crystal, the POU-specific domain recognizes a GCAT half-site, whereas the corresponding sequence recognized by the Pit-1 POU-specific domain, GTAT, is on the opposing strand. As a result, the orientation of the Pit-1 POUspecific domain relative to the POU homeodomain is flipped, as compared to the Oct-1 crystal structure, indicating the remarkable flexibility of the POU-specific domain in adapting to variations in sequence within the site. Also in contrast to the Oct-1 monomer structure is the observation that the POU-specific and POU homeodomain of each Pit-1 molecule make major groove contacts on the same face of the DNA, consistent with the constraints imposed by its 15-amino-acid linker. As a result, the Pit-1 POU domain homodimer essentially surrounds its DNA-binding site (Fig. 1B) .
In the Pit-1 POU domain homodimer the dimerization interface is formed between the carboxy-terminal end of helix 3 of the POU homeodomain of one Pit-1 molecule and the amino terminus of helix 1 and the loop between helices 3 and 4 of the POU-specific domain of the other Pit-1 molecule. In contrast to other homeodomain crystal structures, the carboxyl terminus of helix 3 in the Pit-1 POU homeodomain has an extended structure (Jacobson et al. 1997) as observed in the N M R solution structure of Oct-l, Oct-2, and Oct-3 POU homeodomains (Sivaraja et al. 1994; Cox et al. 1995; Morita et al. 1995) . The flexibility of the carboxyl terminus of POU homeodomains may account for the relatively low affinity of the POU homeodomain for D N A in the absence of a POU-specific domain. In the Pit-1 POU domain crystal structure, this flexibility is important for dimerization. Interestingly, the most common mutation in the h u m a n Pit-1 gene that is associated with combined pituitary hormone deficiencies (R271W), maps within the dimerization interface (Radovick et al. 1992; Cohen et al. 1995) .
Pit-1 and Oct-1 are phosphorylated in vitro by protein kinase A (Kapiloff et al. 1991; Segil et al. 1991) and in vivo by a cell cycle-dependent kinase (Segil et al. 1991; Caelles et al. 1995) at position 7 of their homeodomains, Thr-220 and Ser-385, respectively. Phosphorylation of Ser-385 in Oct-1 inhibits binding to an octamer element in the histone H2B promoter (Segil et al. 1991) . Although phosphorylation of the Pit-1 homeodomain at Thr-220 is generally inhibitory to binding (Kapiloff et al. 1991; Cae-lles et al. 1995) , the magnitude of the effect is dependent on the DNA recognition element (Kapiloff et al. 1991) . The differential effects of POU homeodomain phosphorylation on DNA binding probably reflects the relative distance between the phosphoacceptor amino acids and the DNA; Ser-385 in the Oct-1 crystal is only 3.6 _A from the DNA backbone (Klemm et al. 1994) , whereas in the Pit-1 crystal Thr-220 is almost twice as far away from the backbone, -7 A (Jacobson et al. 1997) . The difference in these distances appears to be a direct result of the degree to which Oct-1 and Pit-1 bend the DNA upon binding (Klemm et al. 1994; Jacobson et al. 1997) .
Function of the POU domain linker in variable DNA site recognition
The disordered linker region observed in both the Oct-1 and Pit-1 crystal structures supports previous hypotheses that a main function of the linker is simply to tether the POU-specific and POU homeodomains, effectively increasing the local concentrations of these two subdomains, thereby aiding high-affinity, site-specific DNA binding by the POU domain. The length of the linker region, which ranges in size from 15 to 56 amino acids, is likely to play an important role in enabling the POUspecific domain to assume various orientations relative to the POU homeodomain and, consequently, in determining the versatility with which POU domains can recognize various DNA elements. For instance, some class III POU domain proteins, which have a 17-amino-acid linker, can accommodate spacings of 0, 2, or 3 nucleotides between the DNA half-sites when the POU-specific and POU homeodomain are in one of the two possible orientations. This class of POU domain proteins can also bind with high affinity to sites where the relative orientation of the POU-specific and POU homeodomain is analogous to that of Oct-1 on its cognate DNA site (Li et al. 1993; Certel et al. 1996; Malik et al. 1996) .
DNA-binding sites dictate cofactor interactions
These considerations begin to account for the ability of POU domain proteins to recognize a diverse array of DNA-binding sites. The additional binding sites identified for several POU domain proteins are generally A/T rich and/or variants of the octamer motif, consistent with the flexibility of orientation of the two POU domain DNA-binding motifs (for examples, see Xiang et al. 1995; Dawson et al. 1996; Malik et al. 1996; Okazawa et al. 1996; Gruber et al. 1997) .
The ability of a DNA-binding site to determine POU domain coactivator interactions has been examined best for Oct-l, for which two site-dependent POU domaininteracting factors have been identified. In addition to its functions in adenovirus DNA replication and the regulation of housekeeping and temporally and spatially restricted gene expression, the ubiquitously expressed Oct-1 is required for initiation of viral gene expression in herpes simplex virus (HSV)-infected cells (for review, see Verrijzer and Van der Vliet 1993; Wegner et al. 1993a; Herr and Cleary 1995) . Upon HSV infection, the viral activator protein VP16 first interacts with the multisubunit host cell factor HCF and then associates with Oct-1 but only when it is bound to a TAAT motif flanked by GARAT (R =purine), in the presence (OCTA ÷) TAATGARAT, or absence (OCTA-) TAATGARAT of an octamer element Kristie et al. 1989) . Alone, VP16 does not effectively bind DNA, and whether or not VP16 contacts DNA in the context of the Oct-1/VP16/HCF complex remains controversial (Kristie and Sharp 1990; Stern and Herr 1991; Walker et al. 1994) . However, it is clear that the presence of a GARAT flanking region alters the conformation of Oct-1 on DNA and permits its interaction with VP16 (Walker et al. 1994; Cleary and Herr 1995) . The POU homeodomain always recognizes the TAAT portion of the site, whereas the POU-specific domain exhibits flexibility in binding and seemingly is able to contact either the GARAT or, in the case of (OCTA+)TAATGARAT elements, the ATGC in the octamer site. An additional layer of conformational specificity can be inferred by the observation that the bovine herpesvirus VP16 counterpart is able to distinguish between Oct-1 bound to a HSV TAATGARAT element and Oct-1 bound to a TAATGARAT element from a bovine herpesvirus immediate early gene (Huang and Herr 1996; Misra et al. 1996) .
The recent cloning of the Oct-l/Oct-2 B cell-specific coactivator OCA-B/Bob-1/OBF-1 (Gstaiger et al. 1995; Luo and Roeder 1995; Pfisterer et al. 1995; Strubin et al. 1995) has permitted further characterization of its interactions with Oct-1. The extent to which OCA-B enhances octamer-dependent transcription is promoter dependent, suggesting that sequences flanking the octamer element are important. Although full-length OCA-B does not bind DNA (Luo and Roeder 1995) , its ability to interact with the Oct-1 POU-specific domain is dependent on an amino-terminal domain that contains a transferable transactivation domain that in isolation binds DNA in a sequence-specific manner (Gstaiger et al. 1995) . The A/T base pair at position 5 in the ATG-CAAAT octamer element is contacted by OCA-B and is critical for a functional OCA-B interaction with Oct-l, although the two half-sites could be spaced by 2 bp without disrupting the OCA-B/Oct-1/DNA complex (Cepek et al. 1996; Gstaiger et al. 1996) . Interestingly, this is the same base pair that is required for cooperative DNA binding by the Oct-1 POU-specific domain and POU homeodomain (Klemm and Pabo 1996) .
Site-dependent coactivator usage is likely to prove prototypic for transcriptional activation by many POU domain proteins. For instance, Oct-3/4 has two transactivation domains (Imagawa et al. 1991; Sch61er et al. 1991; Vigano and Staudt 1996; Brehm et al. 1997) , one of which functions in a cell line-specific manner. This activation domain does not exhibit cell line-restricted expression when linked to the Pit-1 POU domain, implying that the specificity of its function is determined at least in part by the unique configuration assumed by the Oct-3/4 POU domain upon DNA binding (Vigano and Staudt 1996; Brehm et al. 1997 ). In addition, the ability of a monomer of Pit-1 and the estrogen receptor to synergistically activate the prolactin gene (Crenshaw et al. 1989; Day et al. 1990; Simmons et al. 1990 ) is dependent on a specific motif in the Pit-1 amino terminus (Holloway et al. 1995) . In contrast, on a dimer Pit-1 DNA-binding site, this domain is no longer required for synergy with the estrogen receptor.
Biological roles of POU domain transcription factors
The expression patterns of POU domain proteins, particularly in the developing nervous system, have suggested that they might function in embryogenesis, both early and during the terminal differentiation of specific cell types, and potential target genes for many of these factors have been predicted based on in vitro cotransfection analysis. However, in many instances, the expression of target genes identified in vitro has been unaffected in animals that are null for either the gene or the functional protein, emphasizing that in vivo characterization of their functions is essential to define their critical biological roles. Therefore, we review the results for all members of this family whose functions have been determined by in vivo analysis.
POU domain proteins in early embryogenesis

Class V POU domain proteins regulate early events in embryogenesis
Class V POU domain proteins are expressed almost exclusively during the early stages of embryonic development. Xenopus XLPOU-60 (Hinkley et al. 1992; Whitfield et al. 1993) , zebrafish pou2 (Takeda et al. 1994; Hauptmann and Gerster 1995) , and mammalian 0ct-3/4 (Rosner et al. 1990; Sch61er et al. 1990 ) are initially expressed as maternal transcripts. Interestingly, XLPOU-60 undergoes a cell-autonomous change in its intracellular distribution from cytoplasmic to nuclear, coincident with the onset of zygotic transcription, suggesting that it may be an important regulator of gene expression in the early embryo (Whitfield et al. 1995 ). An interspersed RNA family member may be responsible for retaining XLPOU-60 in the cytoplasm (Guttridge and Smith 1995) . The dramatic decrease in XLPOU-60 expression during gastrulation correlates with the sequential up-regulation of the class V proteins 0ct-25 and Oct-91/XLPOU-91 (Frank and Harland 1992; Hinkley et al. 1992) , suggesting that these latter proteins are early products of zygotic transcription. 0ct-25 and Oct-91~ XLPOU-91 expression are subsequently down-regulated during the late gastrula and neurula stages, respectively.
In contrast to XLPOU-60, which seems to be present only as a maternal transcript, pou2 and 0ct-3/4 are also transcribed zygotically (Rosner et al. 1990; Sch61er et al. 1990; Takeda et al. 1994; Hauptmann and Gerster 1995) . Down-regulation of pou2 and 0ct-3/4 gene expression correlates with the loss of pluripotency, such that, as cells differentiate and lose their capacity to develop along multiple pathways, expression of 0ct-3/4 and pou2 is decreased. In the adult, Oct-3/4 is only detectable in the ovaries (Rosner et al. 1990; Sch61er et al. 19901 . A second mammalian class V gene, Sprm-1, is expressed transiently in male germ cells (Andersen et al. 1993a) . Enhancers that regulate distinct portions of the 0ct-3/4 expression pattern have been identified . During retinoic acid-mediated differentiation of P19 cells, expression of the epiblast-specific enhancer is diminished, suggesting that retinoic acid present in Hensen's node may be partially responsible for down-regulation of 0ct-3/4 expression in vivo (Minucci et al. 1996; Yeom et al. 1996) . In contrast, pou2 expression in the prospective rhombomeres appears to be positively regulated by retinoic acid (Hauptmann and Gerster 1995) .
The expression patterns of the class V POU domain proteins suggest that they may function to regulate genes critical for early cell fate determination and cell proliferation. In zebrafish, overexpression of a truncated version of Pou2 that lacks the homeodomain t-Pou2 prevented embryos from proceeding normally through gastrulation (Takeda et al. 1994 ). These results suggest that targeted disruption of the murine Oct-3/4 locus may also result in an early embryonic phenotype. Presumably tPou2 inhibits the interaction of the endogenous fulllength Pou2 with specific cofactors or coactivators via squelching. Disruption of the Sprm-1 genomic locus results in decreased fertility, which, although subtle, could be significantly detrimental to genetic fitness (R.V. Pearse II, D.W. Drolet, K.A. Kalla, F. Hooshmand, J.R. Bermingham, Jr., and M.G. Rosenfeld, in prep.).
CEH-18 regulates oogenesis
The C. elegans POU domain protein CEH-18 may define a novel class of POU proteins. It has a POU-specific domain that is closely related to the mammalian class II POU domain proteins, but its linker and POU homeodomain are significantly more divergent (Greenstein et al. 19941 . CEH-18 is expressed in the gonadal sheath cells, which are responsible for signaling the oocyte to maintain meiotic arrest before fertilization; male gonads lack sheath cells and the process of spermatogenesis does not contain a meiotic arrest point. In ceh-18 mutant hermaphrodites, the process of oogenesis is affected, resulting in misshapen and polyploid oocytes, presumably as a result of an inability to maintain cell cycle arrest during development of the oocyte. Whether CEH-18 is a direct regulator of the meiotic arrest signal or is required to regulate processes required for sheath cell terminal differentiation remains to be determined. Mutational analysis indicates that CEH-18 also functions in gonadal migration and epidermal differentiation (Greenstein et al. 1994 ).
POU domain proteins regulate lineage progression
Characterization of mutations in the C. elegans unc-86, Drosophila pdm-1 and pdm-2, and mammalian Pit-i genes indicates that their products regulate crucial as-pects of lineage progression. Their expression patterns and the phenotype resulting from loss-of-function and/ or gain-of-function m u t a t i o n s suggest that each employs a unique biological m e c h a n i s m to regulate this process.
Unc-86 couples lineage and identity
Unc-86 was the first C. elegans POU domain protein to be identified . M u t a t i o n s in the unc-86 locus demonstrate that it is required for correct neuroblast lineage progression and terminal differentiation of neurons (Chalfie et al. 1981; Desai et al. 1988) . In several neuroblast lineages, Unc-86 is expressed in only one of the two daughter cells resulting from an a s y m m e t r i c neuroblast division (Finney and R u v k u n 1990) . In the absence of functional Unc-86 protein, the daughter cell reiterates the p h e n o t y p e of the m o t h e r cell, and consequently some neurons in the lineage are duplicated, whereas others are lost Finney and Ruvkun 1990) . Thus, Unc-86 must regulate the transcription of genes whose products change the fate of the Unc-86 positive cell from that of its mother. This is illustrated for the Q neuroblast lineage in Figure  2A . Similar parental reiteration also occurs in the V5 and T lineages of unc-86 mutants (Chalfie et al. 1981) .
In a subset of touch receptor neurons that are dependent on the LIM-homeodomain protein Mec-3 for their terminal differentiation (Way and Chalfie 1988), unc-86 is required both for maintenance of the precursor cells and for the initial activation of the mec-3 gene (Xue et al. 1992 ). Unc-86 and Mec-3 then cooperatively interact to synergistically maintain mec-3 gene expression (Xue et al. 1993; Lichtsteiner and Tjian 1995) . Unc-86 is also an important regulator of terminal differentiation events in hermaphrodite-specific neurons (HSNs; Desai et al. 1988 ). In unc-86 mutants, the HSNs fail to mature morphologically and they neither make correct axonal projections nor express serotonin. Thus, Uric-86 regulates genes required for lineage progression as well as genes required for terminal differentiation of neurons, thereby coupling lineage and cell identity (Finney and Ruvkun 1990) .
The complex pattern of asymmetric unc-86 expression is both positively and negatively regulated in a lineagespecific fashion by members of several families of transcription factors, including those containing classic homeodomains, LIM-homeodomains, paired homeodomains, and basic helix-loop-helix (bHLH) family members (Baumeister et al. 1996) . Following its initial activation, Unc-86 maintains its own expression through multiple autoregulatory elements embedded in the lineage-specific enhancers of the unc-86 gene.
Pdm-1 and Pdm-2 are required for generation of RP2 motor neurons
The genetically linked POU domain genes pdm-1 (nubbin, are most closely related to the mammalian class II factors Oct-1 and Oct-2 (Billin et al. 1991; Dick et al. 1991; Lloyd and Sakonju 1991; Prakash et al. 1992; Cockerill et al. 1993; Ng et al. 1995) . Although these factors exhibit gap-like expression patterns in the early embryo and are expressed in the embryonic gut and wing imaginal disc (Affoher et al. 1993; Ng et al. 1995) , they have been studied most extensively in the NB4-2 neuroblast lineage. The NB4-2 neuroblast divides to produce a ganglion mother cell (GMC), which subsequently divides to give rise to an RP2 motor neuron and a sibling cell of undetermined fate. Pdm-1 and Pdm-2 are both expressed in the GMC, but neither is expressed in RP2 motor neurons (Yang et al. 1993) . Overexpression of Pdm results in reiteration of the GMC, suggesting that Pdm is required for specification of GMC identity and that down-regulation of Pdm expression prior to the final division of the GMC is a critical component of its differentiation [see Fig. 2B ; Yang et al. 1993; Bhat and Schedl 1994; Bhat et al. 1995; Yeo et al. 1995) . Both pdm-1 and pdm-2 are required to achieve a full complement of RP2 motor neurons; deletion of either gene diminishes the number of mature RP2 motor neurons, although disruption of both loci results in a complete absence of RP2 motor neurons without affecting the birth of GMCs (Bhat and Schedl 1994; Bhat et al. 1995; Yeo et al. 1995) . Expression of pdm-1 and pdm-2 is required only transiently during NB4 lineage progression and its continued expression prevents lineage progression, unlike unc-86, which is expressed in multiple generations of some lineages and is required for expression of target genes in terminally differentiated neurons.
Pdm-1 is also required for the appropriate differentiation and proliferation of the Drosophila wing . In the wing primordium, expression of pdm-1/ nubbin is dependent on the wingless signaling protein (Ng et al. 1996) . Mutations in the pdm-1/nubbin locus lead to an almost complete deletion of the adult wing, suggesting a role for Pdm-1 in a previously undefined wing growth control center .
Pit-1 is required for three pituitary lineages
Pit-1 was cloned based on its ability to interact with elements required for the pituitary-specific expression of the prolactin and growth hormone genes (Bodner et al.
1988; Ingraham et al. 1988). Expression of Pit-1 is limited
to the pituitary and, in mice, is observed first in the caudomedial region of the developing anterior pituitary gland on day 13.5 of embryogenesis (Dol14 et al. 1990; Simmons et al. 1990 ). In the mature gland Pit-1 is expressed in three cell types: thyrotropes, which express thyroid-stimulating hormone (TSH); lactotropes, which express prolactin (PRL); and somatotropes, which express growth hormone (GH) Simmons et al. 1990 ). Expression of Pit-1 in heterologous cell lines is sufficient to partially transactivate the pituitaryspecific PRL, GH, and TSH~ promoters (for review, see Andersen and Rosenfeld 1994) . The Snell and Jackson dwarf mice, which have mutations in the Pit-1 locus, have hypoplastic pituitaries and lack the somatotrope, lactotrope, and thyrotrope lineages as determined by the absence of their respective trophic hormones ( Fig. 2C ; Li et al. 1990 ). Point mutations in the human Pit-1 gene result in a similar phenotype; different allelic mutations cause subtle distinctions in their phenotypes (Pfaffle et al. 1992; Radovick et al. 1992; Cohen et al. 1995) . Thus, Pit-1 is responsible for the differentiation of specific cell types, regulation of distal target genes, and for the proliferation/survival of cell types within its lineage.
In Snell dwarf mice the initial activation of the Pit-1 gene occurs normally, but expression of the gene is later extinguished, which suggests that Pit-l, like unc-86, is autoregulated (Rhodes et al. 1993) . Although there are Pit-l-binding sites in the promoter (Chen et al. 1990; McCormick et al. 1990 ), a distal enhancer capable of conferring this autoregulation has been identified (Rhodes et al. 1993) . Each of the three Pit-l-positive cell types expresses only one trophic hormone, reflecting an additional layer of activating and restricting mechanisms within the Pit-l-dependent lineages. Pit-1 function appears to be modulated both by specific coactivators and by interactions with other classes of homeodomain proteins (Seidah et al. 1994; Bach et al. 1995; Zhadanov et al. 1995; Lamonerie et al. 1996; Szeto et al. 1996) . A second genetic dwarf mouse, the Ames mouse, is phenotypically similar to the Snell and Jackson dwarf mice, having a hypoplastic anterior pituitary gland with few, if any, somatotropes, lactotropes, or thyrotropes, and failing to effectively express the Pit-1 gene (Andersen et al. 1995; Gage et al. 1996} , indicating that the Ames mutation is epistatic to Pit-1. Recently, a positional cloning approach identified a pituitary-specific paired-like homeodomain protein, Prophet of Pit-1 (Prop-1), as the candidate for the Ames gene product (Sornson et al. 1996) . Prop-1 is capable of binding to sites in an early enhancer of the Pit-1 gene, distinct from the autoregulated late enhancer (DiMattia et al. 1997) , and regulating its expression. A point mutation in helix 1 of the Prop-1 homeodomain that impairs its function was identified in the Ames mouse (Sornson et al. 1996} . The defect observed in the Ames dwarf appears to reflect a failure of determination of the Pit-1 lineages from perilumenal pituitary cells, suggesting that Prop-1 is required for the asymmetric division that establishes the Pit-1 lineages.
POU domain proteins regulate terminal differentiation events
Oct-2 regulates terminal differentiation in the immune system
Expression of Oct-2 at all stages of B cell differentiation and its ability to regulate expression of B cell-restricted genes in vitro suggested that it would be a critical regulator of these events (for review, see Staudt and Lenardo 1991) . However, targeted mutagenesis of the Oct-2 locus demonstrated that although vital for the viability of the newborn mouse, Oct-2 is not required for fetal B lymphocyte development (Corcoran et al. 1993) . Pre-B cells progress normally through the early and antigen-independent stages of differentiation, including transcription and rearrangement of the immunoglobulin genes, and the transcription rates of genes characteristically expressed in B cells remain unaltered (Corcoran et al. 1993) except for the CD36 and CRISP-3 loci Pfisterer et al. 1996) . Oct-2 null B cells are defective in their ability to respond to stimulation by polyclonal mitogens and to secrete immunoglobulins (Corcoran et al. 1993; Corcoran and Karvelas 1994) . Disruption of the Oct-2 locus in cell lines results in a late phenotype like that seen in the Oct-2 null mouse (Feldhaus et al. 1993) .
The ubiquitously expressed Oct-1 and the B cell-specific coactivator OCA-B may compensate for the absence of Oct-2 and to appropriately regulate the expression of genes required during the early stages of B cell differentiation in Oct-2 null mice. Mice that are null for the OCA-B locus are viable and appear healthy and fertile but have a dramatically weakened immune response Nielsen et al. 1996; Schubart et al. 1996) . As in the Oct-2 null mouse, the first stages of B cell differentiation seem to be unaffected, although the progression to mature B cells following antigen stimulation is affected and a severe deficiency in the production of secondary immunoglobulin isotypes is observed Nielsen et al. 1996; Schubart et al. 1996) . Thus, the events required for differentiation of immunoglobulin-secreting B cells are dependent on both Oct-2 and OCA-B and the additional effects observed in the Oct-2 null mice are probably not related to its interactions with OCA-B.
POU domain factors in development of the nervous system
A significant number of POU domain proteins are expressed primarily or exclusively in the nervous system. The class III and VI POU domain proteins are expressed broadly during central nervous system (CNS) development, assuming a more restricted pattern as development and differentiation proceed, whereas members of class IV, which are predominantly expressed in the peripheral nervous system (PNS), have a more restricted pattern of expression in the CNS.
Class III POU domain proteins
Four intronless mammalian class III POU genes, Brn-1, Brn-2, Brn-4, and Tst-1/Oct-6/SCIP have been identified; Tst-1/Oct-6/SCIP is the most divergent member of this class (He et al. 1989; Monuki et al. 1989; Meijer et al. 1990; Suzuki et al. 1990; Hara et al. 1992; LeMoine and Young 1992; Mathis et al. 1992 ). Class III POU domain genes identified in Drosophila (Johnson and Hirsh 1990) , Xenopus (Agarwal and Sato 1991; Baltzinger et al. 1992) , and zebrafish (Matsuzaki et al. 1992; Hauptmann and Gerster 1996; Sampath and Stuart 1996; Spaniol et al. 1996) are also expressed predominantly in the CNS.
Brn-2
The broad expression of Brn-1 and Brn-2 in embryogenesis and antisense RNA experiments, which showed that Brn-2 is potentially required for retinoic acid-induced differentiation of P19 cells (Fujii and Hamada 1993) , suggested that they would potentially perform critical functions in early neurogenesis. However, gross histological analysis of Brn-2 null mice indicated that although they do not survive beyond postnatal day 10, the majority of early neurogenic events are unaffected (Nakai et al. 1995; Schonemann et al. 1995) . Deletion of the Brn-2 locus does have a profound effect on development of the endocrine hypothalamus. In Brn-2 null mice, the paraventricular and supraoptic nuclei are markedly hypocellular and do not produce corticotropin-releasing hormone (CRH), oxytocin, or vasopressin (Nakai et al. 1995; Schonemann et al. 1995) . However, the expression of other neuropeptide genes expressed in the hypothalamus, including somatostatin, GH-releasing hormone, and thy-R y a n and R o s e n f e l d rotropin-releasing h o r m o n e are relatively unaffected (Schonemann et al. 1995) . The presumptive supraoptic and paraventricular h y p o t h a l a m i c neuronal precursors do not survive beyond embryonic day 16, and consequently they never m a k e axonal projections to the median e m i n e n c e or to the posterior lobe of the pituitary, resulting in its absence ( Fig. 3A ; N a k a i et al. 1995; Schon e m a n n et al. 1995).
Neurons that produce oxytocin and CRH primarily express Brn-2, whereas the vasopressin-expressing neurons GENES & DEVELOPMENT (Schonemann et al. 1995; Malik et al. 1996) . Only a small percentage of thryotropin-releasing hormonepositive neurons contain transcripts encoding class III POU domain proteins (Malik et al. 1996) . Although Brn-2 appears to be present in these hypothalamic neurons from their inception, it is not required for their initial differentiation, including commitment to neural fate and the onset of their lateral migration from the third ventricle. However, Brn-2 is required for the survival of these neurons and potentially the expression of their neuropeptides. The relatively late phenotype in the Brn-2 null mouse parallels what was observed in the Oct-2 null mouse; although present early, these factors are essential only for the final stages of differentiation in cells in which they are expressed. The inability of Brn-4, which is coexpressed with Brn-2 in at least those neurons expressing vasopressin, to compensate for Brn-2 in terminal differentiation of these neurons may be analogous to the apparent inability of Oct-1 to substitute for Oct-2 in terminal B cell maturation. The discrepancy between Brn-2 antisense experiments, which predicted that Brn-2 would be required for early events in neural development, and the phenotype of the Brn-2 null mouse, could reflect issues of antisense experiments or/ and distinctions between pluripotent P19 cells and neuronal stem cells.
XLPOU-2
The role of the Xenopus Brn-4 homolog XLPOU-2 in neurogenesis has been addressed via gain-of-function experiments (Witta et al. 1995) . XLPOU-2 is initially expressed in Spemann's organizer and then in the involuting mesoderm and the overlying neuroectoderm of gastrula stage embryos. Expression of XLPO U-2 in the neural plate is temporally correlated with neural induction and overexpression and/or misexpression of XLPOU-2 in uncommitted ectoderm results in the induction of the neural-specific markers neural cell adhesion molecule (NCAM) and ~3-tubulin but not of regionspecific markers (Witta et al. 1995) . XLPO U-2 expression is induced by noggin, suggesting that it may regulate early events in neurogenesis. Overexpression of XLPOU-2 has also been demonstrated to affect gene expression in Spemann's organizer and suggests that XLPOU-2 may function to regulate pathways responsible for dorsalization of Xenopus embryos (Witta and Sato 1997) . In addition to the nervous system, the mammalian Brn-4 homolog is expressed in the outer sheath of whisker roots, the otic vesicle, and limb muscle (Hara et al. 1992; LeMoine and Young 1992; Mathis et al. 1992; Dominov and Miller 1996) . However, mutations in the human Brn-4 locus, PO U3F4, result in deafness associated with a stapes defect but no other recognized neuronal abnormalities (de Kok et al. 1995) , indicating that in humans the potential neurogenic activity exhibited by XLPOU-2 may be subserved by another class III POU domain protein.
Tst-1/Oct-6/SCIP
Tst-1/Oct-6/SCIP (suppressed cAMP-induced POU) (He et al. 1989; Monuki et al. 1989; Meijer et al. 1990; Suzuki et al. 1990 ) has been characterized primarily with respect to its expression in oligodendrocyte precursors and in developing Schwann cells, which are responsible for myelination in the CNS and PNS, respectively (Monuki et al. 1990; Collarini et al. 1991; Jensen et al. 1993; Monuki et al. 1993; Scherer et al. 1994) , where it has been hypothesized to repress myelination (Monuki et al. 1990 (Monuki et al. , 1993 He et al. 1991) . Tst-1/Oct-6/SCIP is also expressed in undifferentiated embryonic stem cells (Meijer et al. 1990; Suzuki et al. 1990 ), early embryonic ectoderm , keratinocytes (He et al. 1989; Faus et al. 1994) , and in the developing neuroepithelium and several nuclei in the developing and mature brain (He et al. 1989; Frantz et al. 1994; Alvarez-Bolado et al. 1995; Zwart et al. 1996} .
Tst-1/Oct-6/SCIP null mice proceed normally through the early stages of embryogenesis, yet the majority die shortly thereafter [Bermingham et al. 1996; Jaegle et al. 1996) . Although central myelination appears to be unaffected in Tst-1/Oct-6/SCIP null mice, peripheral myelination is severely affected a few days after birth. Schwann cells ensheath axons in a 1:1 ratio, but only a small percentage wrap them, indicating a defect in the terminal differentiation of Schwann cells (Fig. 3B) . Myelination does not occur precociously, and the expression of several genes that encode myelin structural proteins, predicted to be repressed by Tst-1/Oct-6/SCIP, is unaffected (Bermingham et al. 1996) or reduced (Jaegle et al. 1996) . Thus, precocious myelination observed when the Tst-1/Oct-6/SCIP POU domain is expressed under the control of the Po promoter (Weinstein et al. 1995) may be a consequence of the inherent activation function of the Tst-1/Oct-6/SCIP POU domain recently described in vitro (Fyodorov and Deveris 1996) . Interestingly, myelination proceeds to completion in Tst-1/Oct-6/SCIP null mice that survive several weeks past their birth (Jaegle et al. 1996} , consistent with the possibility that these mice retain a slow but progressive ability to complete the wrapping process. Thus, the myelination phenotype of Tst-1/Oct-6/SCIP null mice defines a unique regulatory checkpoint in this process and suggests that Tst-1/Oct-6/SCIP regulates expression of a protein that functions as a "molecular catalyst" for the wrapping process. General neuronal development appears to progress relatively normally in Tst-1/Oct-6/ SCIP null mice, although there were several abnormalities, including disruption of the phrenic nucleus and the apparent mismigration and subsequent death of the neurons of the nucleus of the lateral olfactory tract (Bermingham et al. 1996) .
Tst-1/Oct-6/SCIP is capable of synergizing with T antigen to mediate glial-specific transcription of the human papavavirus JC early and late gene expression (Wegner et al. 1993b; Renner et al. 1994) . The amino terminus of T antigen interacts with the Tst-1/Oct-6/SCIP POU domain in a species-and cell type-specific fashion {Sock Cold Spring Harbor Laboratory Press on January 4, 2018 -Published by genesdev.cshlp.org Downloaded from et al. lO96) similarly to what was observed for the interaction of the HSV activator VP16 with Oct-1 (Huang and Herr 1996; Misra et al. 1996) . In addition, the Tst-1/Oct-6//SCIP POU domain can interact with the high mobility group proteins HMG2 and HMG-I/Y (Leger et al. 1995; Zwilling et al. 1995) ; its interaction with HMG-I/Y is required for the activation of the JC early and late genes (Leger et al. 1995) . These studies, in conjunction with the observation that the Tst-1/Oct-6/SCIP aminoterminal transactivation domains function in a cell-specific fashion (Monuki et al. 1993 ) strongly suggest the presence of glial-and neuronal-specific Tst-1/Oct-6/ SCIP coactivators.
Cf l a /ventrai veinless /drifter
Cfla/drifter/ventral veinless is most closely related to Tst-1/Oct-6/SCIP and is the only Drosophila class III POU identified to date. It was initially cloned by its interaction with an element in the dopa decarboxylase gene required for dopaminergic neuron-specific gene expression (Johnson and Hirsh 1990) . During embryogenesis, Cfla/drifter/ventraI veinless is expressed in a pair of midline glia cells, RP3 motor neurons, oenocytes, selected neurons of the ventral nerve cord, in the tracheal placodes and throughout tracheal development, and in wing imaginal discs and wing veins (Anderson et al. 1995; de Celis et al. 1995) . Mutations in the Cfla/ drifter~ventral veinless locus affect growth cone guidance, spacings of the commisures and connections to the CNS, migration of midline glial cells (Anderson et al. 1995; de Celis et al. 1995) , and proliferation and differentiation during wing development (de Celis et al. 1995) . In addition, severe defects in differentiation of the dorsal and visceral aspects of the tracheal tree as a result of mismigration are observed. The tracheal defect in these flies can be rescued by overexpression of the receptor tyrosine kinase gene breathless; Cfla/drifter/ventral veinless maintains the tracheal expression of the breathless gene in wild-type flies .
As with many POU domain proteins, Cfla/drifter/ ventral veinless expression is autoregulated. Autoregulatory elements embedded within tissue-specific enhancers responsible for its midline glia (DFRE1) and tracheal (DFRE2) expression have been identified . The DFRE2 element contains an octamer consensus sequence, whereas the DFRE1 element most closely resembles the Oct-1 TAATGARAT element and is similar to the Cfla/drifter/ventral veinless binding site identified in the dopa decarboxylase promoter, except that the putative core motifs are spaced by 3 nucleotides rather than 0 (Johnson and Hirsh 1990; Certel et al. 1996) . The orientation of the two half-sites in the dopa decarboxylase and midline glia DFRE1 enhancer elements are reversed relative to their orientation in the tracheal DFRE2 octamer element. Thus, like the mammalian class III POU domain protein Brn-2 (Li et al. 1993) , Cf 1 a/drifter/ventral veinless is extremely flexible in its ability to recognize diverse DNA response elements and it is likely that the ability of Cfla/drifter/ ventral veinless to interact with tissue-specific coactivators will be site dependent.
In . In the ventral diencephalon, zp50 is expressed shortly after the appearance of sonic hedgehog (shh) transcripts, and injection of shh transcripts results in the ectopic zp50 expression. An overlap in shh and mammalian Tst-1/Oct-6/SCIP expression has been observed in the rostral diencephalon , raising the possibility that shh may be a regulator of mammalian POU III expression during neural development in mammals.
Class IV POU domain proteins
The class IV POU domain genes identified in mammals (He et al. 1989; Collum et al. 1992; Lillycrop et al. 1992; Gerrero et al. 1993; Ninkina et al. 1993; Xiang et al. 1993; Turner et al. 1994) are highly related to the unc-86 gene product in C. elegans . Similar genes are expressed in Drosophila and zebrafish (Sampath and Stuart 1996). As described earlier, the C. elegans protein Unc-86 is a critical regulator of several neuronal lineages and of terminal differentiation. Recently, the functions of the mammalian class IV factors Brn-3.0/Brn-3a, Brn-3.1/Brn-3c, and Brn-3.2/Brn3b, which have overlapping expression patterns in the CNS and PNS and similar DNA-binding preferences, have been examined in mice following targeted disruption of their loci ( Fig. 3D-F ; Erkman et al. 1996; Ganet al. 1996; McEvilly et al. 1996; Xiang et al. 1996) .
Brn-3.0/Brn-3a
Brn-3.0/Brn-3a is expressed in migrating neural crest cells, the developing and mature sensory ganglia of the PNS, the ganglion cell layer of the retina, and in specific nuclei in the CNS, including the inferior olive, red nucleus, and medial habenula (He et al. 1989; Collum et al. 1992; Gerrero et al. 1993; Turner et al. 1994; Xiang et al. 1995; Fedtsova and Turner 1996; McEvilly et al. 1996) . Targeted disruption of the Brn-3.0/Brn-3a genomic locus has a profound effect on the development of the PNS and several nuclei in which Brn-3.0/Brn-3a is expressed, resulting in severe abnormalities in motor coordination and an ineffective swallowing reflex Xiang et al. 1996) . Neuronal defects are noted in regions of the CNS where Brn-3.0/Brn-3a is uniquely expressed (temporally or spatially) relative to the other class IV POU proteins. Defects in the inferior olive and compact formation of the nucleus ambiguus appear to result from a consequence of neuronal mismi-gration, whereas the cell loss in the red nucleus is likely attributable to the subsequent failure of these neurons to survive following their migration Xiang et al. 1996) . No defects were observed in the newborn retina and the relative number of Brn-3.1/Brn-3c-and Brn-3.2/Brn-3b-positive neurons was similar to wildtype mice (Xiang et al. 1996) . In the PNS the effects of Brn-3.0/Brn-3a gene deletion vary. A severe loss of cells was observed in the acoustic ganglia and the trigeminal ganglia Xiang et al. 1996} . The loss of Bm-3.1/Bm-3c-and Bm-3.2/Brn-3b-positive neurons in both the trigeminal and dorsal root ganglia (DRG) and the marked hypocellularity in the upper cervical DRG in Brn-3.0/Brn-3a null mice was accompanied by significant decreases in the expression of several neurotrophins and their receptors . The upper cervical ganglia were affected more dramatically than lumbar DRG. This gradient in the severity of these effects is consistent with the hypothesis that the progressive differentiation of Brn-3.0/Brn-3a-positive neurons in the DRG occurs in a rostra] to caudal gradient.
Brn-3.1/Brn-3c
Expression of Brn-3.1/Brn-3c is more restricted than that of other class IV family members. In the sensory ganglia and spinal cord, the level of Brn-3.1/Brn-3c expression is significantly lower than either Brn-3.0/Brn-3a or Brn-3.2/Brn-3b Ninkina et al. 1993; Xiang et al. 1995) . However, Brn-3.1/Brn-3c is expressed uniquely and strongly in the hair cells of the inner ear throughout development ). In contrast to Brn-3.0/Brn-3a null mice, Brn-3.1/Brn-3c null mice survive and seem to be grossly normal at birth. However, they soon develop a balance defect and marked hyperactivity by postnatal day 11. Examination of the inner ear reveals that neither the cochlear nor the vestibular hair cells acquire their characteristic morphology, stereocilia are absent, and the mice are deaf . It is hypothesized that in the absence of functional Brn-3.1/Brn-3c protein the hair cells are unable to differentiate properly and provide the trophic support required for the maintenance of the spiral and vestibular sensory ganglia, which also degenerate in Brn-3.1/Brn-3c null mice. Thus, in contrast to mutations in the human Brn-4 locus, PO U3F4, which have been proposed to result in a stapes defect associated with hearing loss, Brn-3.1/Brn-3c null mice are deaf because of improper differentiation of hair cells and the consequent loss of sensory ganglia.
Brn-3.2 /Brn-3b
The Brn-3.2/Bm-3b expression pattern in the PNS and CNS shows significant spatial overlap with that of Brn-3.0/Brn-3a (Lillycrop et al. 1992; Xiang et al. 1993; Turner et al. 1994) . However, there are differences in the temporal aspects and relative levels of expression of the two proteins. During embryogenesis, expression of Brn-3.2/Brn-3b protein in the ganglion cell layer of the retina precedes that of Brn-3.0/Brn-3a protein by -2 days . The main defect observed in mice harboring a targeted disruption of the Brn-3.2/Brn-3b locus is the loss of -70% of retinal ganglion cells Gan et al. 1996) . In Brn-3.2/Brn-3b null mice, these cells display abnormalities before cellular loss occurs, as Bm-3.0/Brn-3a expression is not observed at its normal time of onset, suggesting that these cells are not engaged in the correct differentiation program and that Brn-3.2/Brn-3b is required from its initial expression for the development of retinal ganglion cells. Analysis of these mice revealed that each factor performed a critical function affecting the terminal differentiation of cell types in which their expression pattern is temporally or spatially unique, and will permit interpretation of an expanding literature based on DNA-binding and transfection experiments that have been used to infer gene targets (for review, see McEvilly and Rosenfeld 1997).
Summary
Multidisciplinary approaches have led to the identification of >30 families of DNA-binding proteins, each of which contains members that have arisen following gene duplication and rearrangement events to serve the progressively increased regulatory requirements of more complex metazoans. Examination of the POU domain gene family has provided an opportunity to explore the combination of shared features and functions, as well as the diversity of actions that are assumed by different members within a gene family of transcription factors. An identifying feature of POU domain proteins is their bipartite DNA-binding domain, which can be conceptualized as an intramolecular dimer consisting of two distinct, linked DNA-binding motifs, which permits the flexibility of binding to sites exhibiting different spacing and orientation of core DNA motifs, analogous to that of the heterodimeric binding pairs in the nuclear receptor and bHLH gene families. The ability of the DNA site to allosterically modulate the specificity of POU domain coactivator interactions and the observation that POU domain proteins utilize distinct coactivators, depending upon whether they bind DNA as a monomer or dimer, provides a molecular basis by which specific POU domain proteins can regulate distinct sets of genes with temporal and spatial specificity. The effects of POU domain phosphorylation on DNA binding, the requirement of POU domain proteins in specific gene activation by nuclear receptor ligands, and a specific example of a cellautonomous cytoplasmic to nuclear translocation indicate that POU domain proteins exploit multiple regulatory strategies to execute programs of gene activation.
Most POU domain factors exhibit spatially and temporally restricted expression patterns during development, and these patterns are consistent with the possibility that specific signal transduction pathways are required for their activation. Retinoic acid and the bone morphogenetic protein, hedgehog, and Wnt signaling pathways have been suggested to influence POU domain gene expression either directly or indirectly. Many POU domain factors exhibit autoregulation, providing a type of memory of determination, utilizing distinct mechanisms for their initial activation versus maintenance of their expression. In the case of Pit-l, distinct early and late enhancers have been identified, the latter being autoregulated and sufficient for maintenance of expression.
Consistent with the ontogeny of their expression, several POU domain proteins have been shown to be key regulators of early embryonic development, cell replication, and lineage determination, whereas most exert much later developmental roles. The distinct, yet overlapping expression patterns of class III and IV POU domain genes in the nervous system suggested that they would fulfill roles both early and late in neuronal determination and development. However, the consequence of targeted deletion of individual POU domain loci has been manifest most often by disruption of terminal neuronal differentiation events, including migration, axonal guidance, expression of a series of distal target genes such as neurotrophins and their receptors, and in many cases neuronal survival. Detailed analysis has revealed that altered patterns of gene expression often commence far before detectable morphological changes. These studies reveal that POU domain target genes required for neuronal differentiation and survival include neurotrophic factors and their receptors, other transcription factors, and potentially members of the immunoglobulin superfamily. The relatively restricted phenoptype observed in some of the null mice and the apparent absence of morphological changes early in neural development suggest that the remaining POU domain proteins may be capable of performing compensatory functions in the absence of a closely related family member, a testable hypothesis. Overall, members of the POU domain family appear to function relatively late in developmental transcriptional cascades, regulating events required for terminal differentiation. In addition to their biological roles in gene regulation, POU domain factors appear to have been coopted as a component of a regulatory strategy by which various DNA viruses achieve cell-type specific expression in skin, sensory ganglia, and myelinating glia.
